IDH1 and acute myeloid leukemia: Somatic mutations in cytoplasmic IDH1 and mitochondrial IDH2 are common early drivers in glioma and acute myeloid leukaemia (AML) [1], being most frequent in diffuse gliomas and secondary glioblastoma [2].